NICE – Talk Bio

Actionable Insights Powered by AI

NHS England Approves Groundbreaking CRISPR Gene Therapy for Sickle Cell Disease

3 months ago talkbio0Tagged Anemia, Sickle Cell, Approved, Casgevy, Clustered Regularly Interspaced Short Palindromic Repeats, England, exagamglogene autotemcel, gene therapy, Nance-Horan syndrome, NICE, Nitroglycerin/Sodium Citrate/Ethanol Solution

Casgevy, exagamglogene autotemcel, CRISPR gene therapy, sickle cell disease, NHS England, Vertex Pharmaceuticals, NICE approval

UK Approves Leqembi for Alzheimer’s, but NICE Deems It Too Costly for NHS Use

8 months ago talkbio0Tagged Alzheimer 's disease, Approved, Cost Effectiveness, Leqembi, Nance-Horan syndrome, NICE, Nitroglycerin/Sodium Citrate/Ethanol Solution, UK

Leqembi, Alzheimer’s disease, NICE, NHS, cost-effectiveness, UK approval

Lilly’s Tirzepatide Wins NICE Endorsement for Obesity Treatment with BMI and Weight Loss Conditions

11 months ago talkbio0Tagged Agonist, Body mass index procedure, Eli Lilly, Endorsement, Glucagon-Like Peptide-1 Receptor, Mounjaro, NICE, Nitroglycerin/Sodium Citrate/Ethanol Solution, Obesity, Zepbound

Lilly, tirzepatide, NICE endorsement, obesity treatment, BMI, weight loss, Zepbound, Mounjaro, GLP-1 receptor agonist